The Lawrence J Ellison Institute for Transformative Medicine has lodged plans for the delivery of a new research and development facility at the Oxford Science Park.
The move follows the recent acquisition of a 150-year lease on the 3.5-acre development site, which connects with the 5.9-acre Littlemore House that the institute acquired in December 2021.
The proposed development will be designed by Foster + Partners and is set to reuse much of the existing Littlemore House as a collaboration space. The plans also include extensions to the existing structure to allow the delivery of the research laboratories, an imaging suite, and an oncology and wellness clinic that will treat patients on site.
The extensions mimic the C-shape of the original Littlemore House structure, connecting the two buildings and resulting in a courtyard at its centre. The new facility will also feature a 250-seat auditorium.
David Agus, founding director and chief executive of the institute, said: “This facility, its location and design will play a pivotal role in helping us achieve our vision of not just redefining how cancer and disease are treated, but improving the lives of patients around the world.”
To send feedback, e-mail evelina.grecenko@eg.co.uk or tweet @Gre_Eve or @EGPropertyNews
